Immunosuppressive Therapy for Active Lymphocytic Myocarditis
- 18 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (6), 857-863
- https://doi.org/10.1161/01.cir.0000048147.15962.31
Abstract
Background— The beneficial effect of immunosuppressive treatment on myocarditis is still controversial, possibly because the immunologic and virological profile of potential candidates is largely unknown. Methods and Results— Out of 652 biopsied patients, 112 had a histological diagnosis of active lymphocytic myocarditis; 41 of these 112 patients were characterized by progressive heart failure despite conventional therapy and were treated with prednisone and azathioprine for 6 months. All were resubmitted to cardiac catheterization, angiography, and endomyocardial biopsy at 1 and 6 months and followed-up for 1 year. A total of 21 patients responded with prompt improvement in left ventricular ejection fraction from 25.7±4.1% to 47.1±4.4% and showed evidence of healed myocarditis at control biopsy. Conversely, 20 patients failed to respond and showed a histological evolution toward dilated cardiomyopathy: 12 remained stationary, 3 underwent cardiac transplantation, and 5 died. We retrospectively performed a polymerase chain reaction on frozen endomyocardial tissue for the most common cardiotropic viruses and assessed circulating serum cardiac autoantibodies. Viral genomes were present in biopsy specimens of 17 nonresponders (85%), including enterovirus (n=5), Epstein-Barr virus (n=5) adenovirus (n=4), both adenovirus and enterovirus (n=1), influenza A virus (n=1), parvovirus-B19 (n=1), and in 3 responders, who were all positive for hepatitis C virus. Cardiac autoantibodies were present in 19 responders (90%) and in none of the nonresponders. Conclusions— In patients with active lymphocytic myocarditis, those with circulating cardiac autoantibodies and no viral genome in the myocardium are the most likely to benefit from immunosuppression. The beneficial effect of immunosuppression in hepatitis C virus myocarditis suggests a relevant immunomediated component of damage.Keywords
This publication has 17 references indexed in Scilit:
- Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated CardiomyopathyCirculation, 2001
- Association of Viral Genome with Graft Loss in Children after Cardiac TransplantationNew England Journal of Medicine, 2001
- MyocarditisNew England Journal of Medicine, 2000
- Necrotizing Myocardial Vasculitis in Churg-Strauss SyndromeChest, 1998
- A Clinical Trial of Immunosuppressive Therapy for MyocarditisNew England Journal of Medicine, 1995
- Acute myocarditis. Rapid diagnosis by PCR in children.Circulation, 1994
- Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathyJournal of the American College of Cardiology, 1990
- A Prospective, Randomized, Controlled Trial of Prednisone for Dilated CardiomyopathyNew England Journal of Medicine, 1989
- Effects of prednisolone on acute viral myocarditis in miceJournal of the American College of Cardiology, 1986
- Active Myocarditis in the Spectrum of Acute Dilated CardiomyopathiesNew England Journal of Medicine, 1985